NCT06324916 Donor Site Morbidity After Free Vascularized Fibular Graft
| NCT ID | NCT06324916 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assiut University |
| Condition | Osteosarcoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-01-10 |
| Primary Completion | 2026-01-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2024-01-10 with a primary completion date of 2026-01-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study was carried out at Assiut University to Asses the long-term donor site morbidity following free vascularized fibular transfer because there is a limited information regarding the long-term donor morbidity of this type of flap.
Eligibility Criteria
Inclusion Criteria: * Patients done FVFG for reconstruction of bone defect other than lower limb bone defect. * surgery done \>2yrs * Patient age \> 18 yrs old Exclusion Criteria: Patient age \< 18 Surgery done\< 2yrs FVFG for reconstruction of lower limb bone defct Amputated other leg : Above Ankle Amputaion Double FVFG Fracture of the other leg side : Fracture Tibia, Fibula, Ankle Paraplegic patients
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06324916 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Osteosarcoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06324916 currently recruiting?
Yes, NCT06324916 is actively recruiting participants. Contact the research team at hedra.rafat@yahoo.com for enrollment information.
Where is the NCT06324916 trial being conducted?
This trial is being conducted at Asyut, Egypt.
Who is sponsoring the NCT06324916 clinical trial?
NCT06324916 is sponsored by Assiut University. The trial plans to enroll 20 participants.